Cargando…

Pulmonary arterial hypertension registries: past, present and into the future

Registries have greatly contributed to knowledge about PAH epidemiology, risk factors, prognosis and treatment. Future registries face unique challenges but may benefit from integration of multiple data sources and capitalising on “Big Data” opportunities. http://bit.ly/2OBpapG

Detalles Bibliográficos
Autores principales:	Weatherald, Jason, Reis, Abílio, Sitbon, Olivier, Humbert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488451/ https://www.ncbi.nlm.nih.gov/pubmed/31852747 http://dx.doi.org/10.1183/16000617.0128-2019

Ejemplares similares

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Pulmonary hypertension: Past, present and future
por: Barst, Robyn J.
Publicado: (2008)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?
por: Zelt, Jason G. E., et al.
Publicado: (2022)

Reply to Jha
por: Montani, David, et al.
Publicado: (2022)

Heritable pulmonary hypertension: from bench to bedside
por: Girerd, Barbara, et al.
Publicado: (2017)

Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature
por: Sanges, Sébastien, et al.
Publicado: (2016)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Acupuncture: Past, Present, and Future
por: Hao, Jason Jishun, et al.
Publicado: (2014)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Sex and gender in lung health and disease: more than just Xs and Ys
por: Weatherald, Jason, et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Mycoviruses: Past, Present, and Future
por: Kotta-Loizou, Ioly
Publicado: (2019)

Aging: past, present and future
por: Blagosklonny, Mikhail V., et al.
Publicado: (2009)

ALPPS: PAST, PRESENT AND FUTURE
por: TORRES, Orlando Jorge M, et al.
Publicado: (2015)

Cardiomyopathies—past, present, future
por: Maisch, Bernhard, et al.
Publicado: (2020)

WALANT: Past, Present and the Future
por: Abdullah, Shalimar
Publicado: (2022)

Simulation: past, present, and future
por: Berg, Benjamin Worth
Publicado: (2023)

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
por: Launay, David, et al.
Publicado: (2013)

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
por: Lambert, Mélanie, et al.
Publicado: (2018)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience
por: Sitbon, Olivier, et al.
Publicado: (2017)

Management of pulmonary arterial hypertension in patients aged over 65 years
por: Sitbon, Olivier, et al.
Publicado: (2019)

Beyond a single pathway: combination therapy in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2016)

Takotsubo syndrome: The past, the present and the future
por: Khalid, Nauman, et al.
Publicado: (2019)

Integrated healthcare: the past, present and future
por: Dawda, Paresh
Publicado: (2019)

The past, present and future of clinical research
por: Azeka, Estela, et al.
Publicado: (2011)

Genome Medicine: past, present and future
por: Auffray, Charles, et al.
Publicado: (2011)

Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)

Metabolic Syndrome: Past, Present and Future
por: Lemieux, Isabelle, et al.
Publicado: (2020)

Drug Design—Past, Present, Future
por: Doytchinova, Irini
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3akdohre3irk9d7nnfl3dvj9vv